ストックスクリーナーアプリを入手
97.83
3.23%
-3.27
プレマーケット:
96.94
-0.89
-0.91%
前日終値:
$101.10
開ける：
$101.3
24時間の取引高:
730.60K
Relative Volume:
0.94
時価総額：
$2.92B
収益：
$442.68M
当期純損益:
$-77.81M
株価収益率:
-36.66
EPS:
-2.6684
ネットキャッシュフロー:
$-28.65M
1週間 パフォーマンス:
+9.01%
1か月 パフォーマンス:
+12.36%
6か月 パフォーマンス:
+40.08%
1年 パフォーマンス:
-24.52%
1日の値動き範囲:
$97.14
$102.21
1週間の範囲:
$88.81
$105.18
52週間の値動き範囲:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Compare WGS vs TMO, DHR, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
97.83 | 2.54B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
658.76 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.84 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
370.64 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
161.94 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
269.88 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2025-05-15 | 開始されました | Guggenheim | Buy |
| 2025-05-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-10 | 開始されました | Craig Hallum | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
すべてを表示
Genedx Holdings Corp (WGS) 最新ニュース
GeneDx (WGS) CEO sells shares in tax-withholding trade - Stock Titan
GeneDx (WGS) CFO sells stock for taxes, holds 41,476 shares - Stock Titan
WGS: GeneDx Holdings Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C - Yahoo Finance
GeneDx at Wells Fargo healthcare conference: growth and collections in focus - Investing.com Canada
GeneDx Holdings Corp. (WGS) Latest Stock News & Headlines - Yahoo! Finance Canada
GeneDx Holdings CFO Kevin Feeley Executes 717 Shares at $0 and Sells at $83.84 on Sept. 1, 2026 - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out - ACCESS Newswire
GeneDx to report Q2 2026 financial results on August 3 - scanx.trade
GeneDx Holdings (WGS) CFO sells shares in tax-cover trade - Stock Titan
Insider at GeneDx (NASDAQ: WGS) lines up new stock sale after June tax trades - Stock Titan
Planned $1.2M insider sale at GeneDx (NASDAQ: WGS) tied to 2026 RSU vesting - Stock Titan
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree - marketscreener.com
WGS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against GeneDx Holdings Corp - Eastern Progress
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics AcquisitionHBSS - Eastern Progress
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Eastern Progress
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
GeneDx Holdings (WGS) Study Data Puts Its Fair Value Debate Back In Focus - Sahm
A GeneDx study found genetic diagnoses in 63% of children with faltering growth - Stock Titan
A Look at GeneDx Holdings Corp (WGS) After 5.5% Gain -- GF Value $73.66 vs Price $87.06 - GuruFocus
GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE - MarketBeat
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Cor - The National Law Review
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-08-18 | GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:WGS | Press Release - Stockhouse
GeneDx: Why I Think The Worst Is Behind The Business (NASDAQ:WGS) - Seeking Alpha
WGS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Inv - The National Law Review
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GeneDx Holdings (WGS) Slips 1.35% to $78.08, Holds Midpoint of Trading RangeCall Flow Alert - Vinanet
GeneDx Holdings (WGS) Slips 1.35% as Shares Hold Between Key Support and ResistanceDelta Hedging - Vinanet
GeneDx Holdings (WGS), Why Is This Fresh Development Drawing Attention? - Sahm
Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily
The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire
Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation - simplywall.st
GeneDx launches online exome testing for pediatric patients - Investing.com
GeneDx Lets Families Start Children’s Exome Testing Online - Stock Titan
GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Pioneer with 10.28% Upside Potential - DirectorsTalk Interviews
Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GENEDX HOLDINGS CORP. : PIPER SANDLER RAISES TARGET PRICE TO $95 FROM $63 - Moomoo
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The National Law Review
GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Genedx Holdings Corp (WGS) 財務データ
収益
当期純利益
現金流量
EPS
Genedx Holdings Corp (WGS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 16 '26 |
Sale |
97.61 |
10,501 |
1,025,013 |
115,476 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
48,673 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 16 '26 |
Sale |
97.61 |
3,728 |
363,892 |
44,945 |
| Fuchs Thomas | Director |
Sep 17 '26 |
Option Exercise |
0.00 |
1,146 |
0 |
1,146 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 09 '26 |
Option Exercise |
0.00 |
6,547 |
0 |
110,919 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Sep 09 '26 |
Sale |
84.22 |
3,692 |
310,932 |
107,227 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 09 '26 |
Option Exercise |
0.00 |
2,462 |
0 |
42,761 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 09 '26 |
Sale |
84.22 |
1,285 |
108,220 |
41,476 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 01 '26 |
Option Exercise |
0.00 |
717 |
0 |
40,671 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 01 '26 |
Sale |
83.84 |
372 |
31,188 |
40,299 |
0.64%
2.74%
大文字化:
|
ボリューム (24 時間):